comparemela.com
Home
Live Updates
Ann Thorac - Breaking News
Pages:
2
3
4
5
6
7
8
Latest Breaking News On - Ann thorac - Page 1 : comparemela.com
Improving lung cancer surgery through novel computed tomography
This article from Thermo Scientific outlines how Amira software was used as a tool to perform computed tomography to improve lung cancer surgery.
Chao liu
United states
Huike gao
Emily magee
Journal of international medical research
American cancer society
Thermo fisher
Thermo fisher amira software
Jining medical university
Amira software
Sponsored content
Thermo fisher scientific
Thermo scientific
International medical
Cancer society
Accessed january
Roivios® announces final patient enrollment in feasibility trial for JuxtaFlow® Renal Assist Device (RAD)
ROSWELL, Ga., Dec. 4, 2023 /PRNewswire/ Roivios Ltd., a medical device company pioneering a revolutionary treatment to reduce poor surgical out.
Bielsko biala
Sremska kamenica
United states
Milovan petrovic
Lazar velicki
Dimitrije jeremic
John erbey
Institute of cardiovascular diseases
Prnewswire roivios ltd
Institute for cardiovascular diseases dedinje
Acute kidney injury
Juxtaflow renal assist device
Cardiovascular diseases
Prof dr milovan petrovic
Prof dr lazar velicki
American heart hospital
Sublobar Resection Should Be New Standard Care for Certain Patients With NSCLC
Sublobar resection is noninferior to a full lobectomy in patients with carefully staged cT1aN0 non-small cell lung cancer, new research suggests.
New york
United states
Nasserk altorki
Hisashi saji
Astellas pharma
Merck sharpe dohme
Bristol myers squibb
Chugai pharma
York genome center
Boehringer ingelheim
Takeda pharmaceutical company
Japan blood products organization
Lung cancer study group
Janssen pharmaceuticals
St marianna university school of medicine
Weill cornell medicine
Investigational Adagrasib Delivers Positive Results in Registration-Enabling Study of Patients with KRASG12C-Mutated Advanced Non-Small Cell Lung Cancer
/PRNewswire/ Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced positive results from the.
United states
Alexanderi spira
Charlesm baum
American society of clinical oncology
Virginia cancer specialists research institute
Prnewswire mirati therapeutics inc
Drug administration
Mirati therapeutics inc
Exchange commission
Access program
Clinical oncology
Annual meeting
Non small cell
Clinical results
Enabling study
Blinded independent central review
Investegate |F Hoffmann-La Roche Ltd Announcements | F Hoffmann-La Roche Ltd: CHMP recommends EU approval of Roche s Tecentriq as adjuvant treatment for a subset of people with early-stage non-small cell lung cancer
Investegate announcements from F. Hoffmann-La Roche Ltd, CHMP recommends EU approval of Roche’s Tecentriq as adjuvant treatment for a subset of people with early-stage non-small cell lung cancer
United kingdom
United states
Nathalie meetz
Levi garraway
Europe lu
Roche tecentriq
Sileia urech
Loren kalm
Anne marie baird
Karsten kleine
European lung cancer congress
European commission
World health organization
Head of global product development
European medicines agency
Roche group
vimarsana © 2020. All Rights Reserved.